Want to join the conversation?
$UHS expects FY16 adjusted net income attributable to the company of $7.12-7.58 per diluted share, up 4-10% versus FY15, and net revenue of $9.75-9.85Bil, up 8-9%. In FY16, $UHS expects about $5MM EHR incentive income and about $36MM EHR-related D&A expense, resulting in a net unfavorable after-tax impact of about $17MM or $0.17 per diluted share.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.
$SPY can the rally continue? La Pen almost assured to lose makes me cautious about the results, not a place to panic. If 2400 is reached I'm selling my puts and going for broke. Happy hunting.